|
ZW10 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.84579973106747E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.26879967538218E-10 |
| Normal-vs-Stage2 |
1.298320E-02 |
| Normal-vs-Stage3 |
1.960280E-02 |
| Normal-vs-Stage4 |
8.142300E-03 |
| Stage1-vs-Stage2 |
2.835800E-01 |
| Stage1-vs-Stage3 |
2.041400E-01 |
| Stage1-vs-Stage4 |
8.811200E-01 |
| Stage2-vs-Stage3 |
9.509800E-01 |
| Stage2-vs-Stage4 |
4.185800E-01 |
| Stage3-vs-Stage4 |
4.489800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.74350011994795E-10 |
| Normal-vs-AfricanAmerican |
5.95230000000058E-05 |
| Normal-vs-Asian |
3.378100E-03 |
| Caucasian-vs-AfricanAmerican |
3.849000E-01 |
| Caucasian-vs-Asian |
9.441600E-01 |
| AfricanAmerican-vs-Asian |
8.177800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.49091849976912E-12 |
| Normal-vs-Female |
1.420550E-01 |
| Male-vs-Female |
3.58910000000101E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.72240000000579E-05 |
| Normal-vs-Extreme_Weight |
2.07678318986382E-12 |
| Normal-vs-Obese |
2.176300E-03 |
| Normal-vs-Extreme_Obese |
1.835080E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.281400E-01 |
| Normal_Weight-vs-Obese |
2.531000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.723200E-01 |
| Extreme_Weight-vs-Obese |
6.558800E-03 |
| Extreme_Weight-vs-Extreme_Obese |
6.795600E-01 |
| Obese-vs-Extreme_Obese |
1.394640E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.104200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.09669999970308E-07 |
| Normal-vs-Age(61-80Yrs) |
2.83020273883494E-11 |
| Normal-vs-Age(81-100Yrs) |
1.239110E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.682000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.163500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.210400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.080210E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.222800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.330200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.33744143432568E-12 |
| Normal-VS-Type2 PRCC |
1.46800000000447E-06 |
| Normal-VS-KIRP CIMP |
2.168200E-01 |
| Normal-VS-Unclassified PRCC |
1.457690E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.179900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.558240E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.358000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.035700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.768800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.292400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.95539999969796E-07 |
| Normal-vs-N1 |
4.199200E-01 |
| Normal-vs-N2 |
7.58440000000471E-05 |
| N0-vs-N1 |
6.866100E-02 |
| N0-vs-N2 |
4.080800E-01 |
| N1-vs-N2 |
1.940250E-01 |
|
|
